MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6603-530-537$20.00
Mol Pharmacol 66:530-537, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gruss, M.
Right arrow Articles by Franks, N. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gruss, M.
Right arrow Articles by Franks, N. P.

The Two-Pore-Domain K+ Channels TREK-1 and TASK-3 Are Differentially Modulated by Copper and Zinc

Marco Gruss, Alistair Mathie, William R. Lieb, and Nicholas P. Franks

Biophysics Section, the Blackett Laboratory, Imperial College London, United Kingdom

The "trace" elements copper and zinc are essential for life, and their role in the function of metalloproteins is well known. However, mounting evidence shows that these metals are also capable of modulating neuronal excitability under normal physiological conditions. They are present at high levels in the brain, are concentrated at nerve terminals, and are released at micromolar concentrations into the synaptic cleft after depolarization. They have been shown to affect the function of a number of different voltage- and ligand-gated ion channels, but their most important targets in the nervous system remain uncertain. In this study, we show that the two-pore-domain potassium channels TREK-1 and TASK-3 are potently modulated by both copper and zinc. Copper activates TREK-1 channels by 83 ± 11% with an EC50 of 3.0 ± 1.0 µM, whereas TASK-3 channels are potently inhibited, with an IC50 of 2.7 ± 0.4 µM. Zinc inhibits both channels but with very different affinities. The IC50 for inhibition of TREK-1 channels is 659 ± 94 µM whereas the IC50 for inhibition of TASK-3 is 12.7 ± 1.0 µM. Using site-directed mutagenesis, we show that Asp128 plays a critical role in the copper activation of TREK-1. These observations provide a novel explanation for how copper and zinc might affect neuronal excitability under both normal physiological conditions, as well as during diseases in which copper or zinc homeostasis has been disrupted.


Received February 24, 2004; accepted May 19, 2004

Address correspondence to: Nicholas P. Franks, Biophysics Section, The Blackett Laboratory, Imperial College London, London SW7 2AZ, United Kingdom. E-mail: n.franks{at}imperial.ac.uk




This article has been cited by other articles:


Home page
J. Gen. Physiol.Home page
Z. Ma, K. Y. Wong, and F. T. Horrigan
An Extracellular Cu2+ Binding Site in the Voltage Sensor of BK and Shaker Potassium Channels
J. Gen. Physiol., April 28, 2008; 131(5): 483 - 502.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
H. Liu, J. A. Enyeart, and J. J. Enyeart
Potent Inhibition of Native TREK-1 K+ Channels by Selected Dihydropyridine Ca2+ Channel Antagonists
J. Pharmacol. Exp. Ther., October 1, 2007; 323(1): 39 - 48.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
I. Andres-Enguix, A. Caley, R. Yustos, M. A. Schumacher, P. D. Spanu, R. Dickinson, M. Maze, and N. P. Franks
Determinants of the Anesthetic Sensitivity of Two-pore Domain Acid-sensitive Potassium Channels: MOLECULAR CLONING OF AN ANESTHETIC-ACTIVATED POTASSIUM CHANNEL FROM LYMNAEA STAGNALIS
J. Biol. Chem., July 20, 2007; 282(29): 20977 - 20990.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
S. Lutsenko, N. L. Barnes, M. Y. Bartee, and O. Y. Dmitriev
Function and Regulation of Human Copper-Transporting ATPases
Physiol Rev, July 1, 2007; 87(3): 1011 - 1046.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
A. Traboulsie, J. Chemin, M. Chevalier, J.-F. Quignard, J. Nargeot, and P. Lory
Subunit-specific modulation of T-type calcium channels by zinc
J. Physiol., January 1, 2007; 578(1): 159 - 171.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X. Liu, C. Alexander, J. Serrano, E. Borg, and D. C. Dawson
Variable Reactivity of an Engineered Cysteine at Position 338 in Cystic Fibrosis Transmembrane Conductance Regulator Reflects Different Chemical States of the Thiol
J. Biol. Chem., March 24, 2006; 281(12): 8275 - 8285.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
G. Czirjak and P. Enyedi
Zinc and Mercuric Ions Distinguish TRESK from the Other Two-Pore-Domain K+ Channels
Mol. Pharmacol., March 1, 2006; 69(3): 1024 - 1032.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-S. Kim, J.-Y. Park, H.-W. Kang, E.-J. Lee, H. Bang, and J.-H. Lee
Zinc Activates TREK-2 Potassium Channel Activity
J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 618 - 625.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics